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In recent years, patient-reported outcomes have become increasingly collected 
and integrated into electronic health records. However, there are few cross-cutting 
recommendations and limited guidance available in this rapidly developing research 
area. Our goal is to report key findings from a 2013 Patient-Centered Outcomes 
Research Institute workshop on this topic and a summary of actions that followed from 
the workshop, and present resulting recommendations that address patient, clinical 
and research/quality improvement barriers to regular use. These findings provide 
actionable guidance across research and practice settings to promote and sustain 
widespread adoption of patient-reported outcomes across patient populations, 
healthcare settings and electronic health record systems.
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A patient-reported outcome (PRO) is a mea-
surement obtained directly from the patient 
about health, disease or treatment, without 
amendment or interpretation by a clinician 
or anyone else [1]. PRO is a term that can refer 
to symptoms, functioning, treatment satis-
faction or health-related quality of life [1,2]. 
For many years, PRO collection for research 
purposes has been distinct from clinical prac-
tice applications. Due to technological inno-
vations, there are increasing opportunities 
for PROs to be simultaneously collected and 
applied in both research and practice [3].
Electronic data reporting provides a plat-
form for consistent and real-time documen-
tation of PROs. When integrated into an 
electronic health record (EHR) in the same 
structured clinical data format (e.g., provider 
actions, laboratory tests and referrals), PROs 
can be used to inform individual patient and 
population-level care [4–6]. PRO-structured 
data can inform many stakeholders: pro-
vider, patient, health system and researcher. 
As the US healthcare system moves toward 
large-scale EHR-based data collection, there 
is increasing interest in collecting and stan-
dardizing PRO information [7]. However, 
beyond a handful of published case studies 
and academic pilots [8] little is known about 
current integration efforts.
Integrating Patient-Reported 
Outcomes into the electronic health 
record Workshop
In November 2013, the Patient-Centered 
Outcomes Research Institute (PCORI) and 
its Methodology Committee hosted a PRO 
Infrastructure Workshop (Atlanta, GA, 
USA) to understand current practices inte-
grating PROs into EHR systems, and to gen-
erate broad stakeholder priorities to advance 
and sustain use. This meeting had three main 
goals: a landscape review, panel presentations 
and stakeholder discussion groups.
Patients, clinicians, researchers, healthcare 
system leaders and policymakers were invited 
to present on current use, identify common 
implementation barriers, share examples of 
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clinical, research and quality improvement uses, and 
discuss strategies and priorities for increasing collec-
tion and use of PROs in EHR systems. A vision was 
articulated for integrating PRO measures within EHRs 
and for creating a larger national data infrastructure for 
medical care and public health. At the local level, this 
infrastructure would permit concurrent research and 
evaluation to be conducted more routinely within a real-
world delivery system. It would also allow the care of 
individual patients to benefit from the knowledge and 
experience of those previously treated. This infrastruc-
ture would be fractal, locally used but also aggregating 
up to the regional and national levels. At the national 
level, the overall structure would support widespread 
capability for the US healthcare system to learn from 
practice, quality improvement and research [5,9,10].
Based on a pre-meeting landscape review of the 
field [11], we designed workshop presentations and dis-
cussion groups to learn about the range of current inte-
gration trends. Below are highlights and the key mes-
sages from the workshop, with a focus on how PROs 
most often collected for clinical practice applications 
can be leveraged for broader quality improvement and 
research applications. Following that is a summary of 
progress on the resulting agenda to date.
Workshop agenda: presentation of 
successful models, action agenda 
formulation
Workshop participants included in-person and online 
attendees (see Table 1 for description of participants). 
Panel presentations focusing on specific examples of 
PRO integration in the EHR were followed by full 
group discussion, interspersed with small group break-
out sessions, with an opportunity for all attendees 
to rotate through breakout sessions on three topics: 
patient and PRO data, clinical use of PRO data and 
research and quality measurement. The small group 
breakout sessions proceeded through semi-structured 
discussion to address barriers and facilitators of PRO 
integration in the EHR and to submit recommenda-
tions for concrete actions for prioritization through 
consensus in the final session with all attendees. 
Data were analyzed and guided by basic principles of 
grounded theory [12]. Our thematic content analysis 
began with line-by-line examination of the transcripts. 
Two of the authors independently identified provi-
sional categories and themes (RE Jensen & AW Wu). 
Initial theories were compared against newly identi-
fied themes, synthesis from the discussion, and author 
notes, to ensure validity. Nominal grouping was used 
to reach consensus regarding final categorization 
(Boxes 1 & 2).
Workshop results: current integration trends 
& stakeholders
We found that current integration efforts focus on 
informing and improving clinical care across differ-
ent types of illness and healthcare settings. Very few 
examples were identified of PROs being pulled from 
EHRs for research-specific purposes. We identified 
four predominant EHR/PRO system designs: physi-
cian use during a patient visit; quality assessment and 
improvement; population-based risk screening and 
clinical and health services research. Each design illus-
trates the potential of collecting PROs and integrat-
ing results into the EHR. Current efforts are tailored 
to specific contexts, resulting in a wide range of target 
populations, assessment modalities, data collection 
schedules and external PRO reporting. This degree 
of specificity limits widespread collection across dif-
ferent systems. While goals and methods are similar, 
better understanding of commonalities and a core set 
Table 1. Participant location and affiliation (n = 519).
 Affiliation Primary Secondary Total
In-person (n = 115)
Researcher/academia 17 20 37
Direct care provider 24 9 33
Patient/patient advocate 13 3 16
Industry representative 19 1 20
Researcher (private or 
nonprofit organization)
15 4 19
Government agency 14 0 14
Healthcare payer 6 0 6
Funder 3 0 3
Health system 
representative
3 1 4
Healthcare purchaser 1 0 1
Online (n = 408)
Researcher/academia 159 13 172
Direct care provider 41 3 44
Patient/patient advocate 24 4 28
Industry representative 22 0 22
Researcher (private or 
nonprofit organization)
50 7 57
Government agency 46 0 46
Healthcare payer 2 0 2
Health system 
representative
51 5 56
Funder 13 0 13
Healthcare purchaser 0 0 0
Missing/not reported 0 0 4
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of cross-cutting standards is necessary to provide a 
platform for widespread adoption.
Leading examples in patient-level symptom tracking 
tend to be for specific diseases that benefit from long-
term monitoring, such as rheumatoid arthritis [13–15], 
HIV/AIDS [16] and cancer patients undergoing chemo-
therapy [17]. In these cases, PRO data modified treat-
ment. Risk-screening applications focused on linking 
high-risk scores to targeted interventions. For example, 
at Kaiser Permanente Colorado a positive previsit PRO 
screen triggers standardized order sets to direct testing, 
treatment and referrals for geriatric patients.
Box 1. Recommendations to address current integration barriers.
Addressing patient concerns & promote engagement
•	 Make it easy to complete
 – Provide multiple modes of data collection
 – Reduce patient burden when possible
 – Confirm preferred PRO data collection channels with patients
•	 Make it relevant to patients
 – Involve patients in PRO development
 – Give patients control of data and how it is displayed to them
 – Better understand PRO relevance and importance of specific questions for individual patients prior to 
administration
 – Provide immediate information and create immediate benefits for patients in order to demonstrate and 
advance their interest in PROs
•	 Clarify and address possible ethical issues directly
 – Collect patient consent in a way to encourage collection of PRO measures, and assure that consent 
documents use simple language
 – Provide guidance to Institutional Review Boards for consent and data use
Individual clinical care
•	 Improve clinical interpretability of PROs
 – Measure other patient-reported information in addition to outcomes, such as their experiences with care, 
goals and preferences
 – Determine which measures are most appropriate for specific patients and settings
 – Use PROs to inform shared decision-making and promote individualized care plans
•	 Incentivize regular use
 – Translate PROs into specific actions for clinicians
 – Establish clear recommendations on how to respond to PRO scores in clincal settings
 – Create value-based payment and reimbursement based on collection of PROs or PRO scores achieved
•	 Optimize workflow integration
 – Reduce known technological barriers to electronic health record integration, and real-time, in-clinic review
 – Move away from a measurement model that assumes care is centered on the health system. It will be 
valuable to assess PROs in other settings, including at home or at work
 – Expand options to maximize accessibility of data collection to the greatest number and variety of patients
 – Identify PRO measures and best practices for different contexts – for whom, when and what
Research and quality improvement
•	 PRO standardization and measurement equivalence
 – Better understanding and education of the methodological requirements and differences between 
research and clinical use of PRO information
 – Promote uniformity of PRO scoring, through methodological applications (i.e., IRT-derived crosswalks) and 
setting methodological standards
•	 PRO infrastructure and software needs
 – Establish standards for the development for interoperable PRO tools
 – Develop standards that allow data to be transmitted across different vendors
 – Better understanding of metadata collected along with PRO scores and how it can be used to support 
adoption in quality improvement efforts
•	 Promoting and supporting use
 – Leverage large research networks that have an infrastructure to support the development of PRO-based 
quality measures
 – Work on developing well-defined, quality performance measures at the national level
 – Demonstrate the value of database linkages (e.g., electronic health record, claims data) incorporating 
PROs in the evaluation of clinical care, CER and research applications
CER: Cost–effectiveness research; IRT: Item response theory; PRO: Patient-reported outcome.
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Quality improvement efforts on symptom identifi-
cation and management were identified at all health-
care levels: clinics, practices and populations. For 
example, Minnesota Community Measurement tracks 
and publicly reports PRO-based depression screen-
ings and 6-month remission rates at the clinic level 
from over 80,000 patients annually [18]. In these cases, 
PRO measurement provides information on the PRO 
screening use, symptom prevalence and management.
The final workshop goal was to identify and under-
stand stakeholder perspectives and their interest in 
promoting PRO EHR integration. Healthcare payers, 
such as Medicare, are looking to demonstrate value in 
healthcare beyond mortality and costs, which PRO-
based quality of care indicators could provide. Health-
care plans, specifically integrated healthcare delivery 
systems such as Kaiser Permanente and Group Health 
Cooperative, are looking to leverage their existing 
clinical electronic data collection infrastructure. Clini-
cians and researchers were identified as ‘early adopters’, 
as patient-level PRO collection and use is most com-
monly driven by academic medical centers, often for 
use in specific clinics or conditions funded through 
research grants. Finally, patients themselves are impor-
tant stakeholders, demonstrating increased interest in 
understanding their symptoms and functional issues, 
while current PRO data capture options and interpre-
tation can be provided directly to the patient [19], align-
ing with growing patient expectations for transparency 
and access to medical information.
Meeting conclusions: the paths forward to 
widespread adoption
Stakeholders met in small groups to identify barriers 
and successful strategies to inform a research agenda: 
patient concerns, individual clinical care and large scale 
evaluation (quality improvement and research applica-
tions). Differences in needs, interests and expertise 
resulted in a range of opinions, but each of the groups 
was successful at achieving consensus. Below is a dis-
cussion of the main elements from each topic (Box 1) 
and actionable next steps (Box 2).
The benefits of patient engagement
Discussions regarding patient concerns focused on 
PRO collection. This action requires engaged patients, 
as they must be willing to complete assessments and 
provide responses that accurately reflect their current 
health. Reasonably complete and accurate data are 
needed for the timely identification of new concerns 
and to prevent biased assessment of care quality at the 
population level due to nonresponse.
Patient burden and the amount of time patients 
invest to complete PRO assessments were also impor-
tant considerations. Research indicates that patients 
report high satisfaction completing assessments if they 
think data are used to inform their care [20]. However, 
it is possible that patients with different levels of func-
tioning may value the usefulness of PRO data differ-
ently. Understanding how best to promote relevant 
PRO assessments while identifying the maintaining 
content relevance and low burden may help address 
these concerns.
Beyond promoting patient engagement, ethical 
issues related to the potential harms, respect for per-
sons and privacy concerns related to PRO collection 
were identified. Just as a patient nonresponse to a PRO 
screen may delay issue identification, poor integration 
of PRO collection into patient care may disrupt or 
delay care. Additionally, PRO collection can be annoy-
ing to patients, if it feels redundant or repetitive with 
other information collected in the provision of care.
Finally, workshop participants raised concerns over 
the privacy and protection of their PRO data. Cur-
Box 2. Immediate priorities to advance use of patient-reported outcome data through integration 
into the electronic health record.
Standards and education
•	 Adopt national standards for PRO measurement, data collection, and appropriate use across clinical care, 
research and quality improvement settings
•	 Develop educational materials to guide PRO measure selection and interpretation, with specific attention to 
facilitating EHR integration
Research
•	 Demonstrate usefulness of combining and reconciling PRO and clinical EHR data
•	 Determine patient preferences for privacy and sharing of PRO data
•	 Identify optimal strategies to reduce and manage missing data in PRO collection
Infrastructure
•	 Develop tools and resources needed for large-scale, sustainable use of PROs within healthcare through EHR 
platforms
•	 Promote an infrastructure and interoperability for large-scale PRO collection. (e.g., PCORNet)
•	 Collaborate with payer organizations to evaluate payment models for PRO data collection and use
EHR: Electronic health record; PRO: Patient-reported outcome.
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rently, many institutions require a blanket consent 
process, where patients give general consent for use 
of all of their data, clinical and patient-reported. To 
date, no published work has explored the extent to 
which sensitive PRO data is restricted within the EHR 
(e.g., assessments of a patient’s satisfaction with care), 
or outside the EHR (e.g., disclosure of depression 
severity to family members). Providing clear assur-
ances of data privacy, clinical benefit and recognizing 
patient burden may help address these concerns and 
help promote patient involvement.
Themes from these small group sessions focus on 
improving the individual-level patient experience by 
increasing the clarity and relevance of clinical PRO 
assessment. Due to the limited information available 
and strong interest in ethical and privacy issues sur-
rounding EHR integration, a targeted recommendation 
was identified as a necessary and immediate priority.
Simplifying & promoting clinical use
Clinical use focused on how PRO collection could 
be best integrated into every-day clinical care. A key 
issue voiced by workshop participants was the current 
established dichotomy between clinical and PRO-
based measures in care settings. Many participants 
felt the benefits of PRO integration are not currently 
well-communicated and PROs often feel irrelevant and 
unimportant relative to clinical laboratory values. Cli-
nicians also need guidance for interpreting PRO data, 
to ensure the data are translated into clinical actions 
as appropriate. A provider may see an ‘anxiety’ score 
of 60, but not know if it is a concerning score or if 
follow-up is necessary.
Many possible solutions were identified. One was 
to move beyond symptoms and function by includ-
ing patient goals, treatment preferences and experience 
of care. Financial incentives were also highlighted as 
a way to promote and disseminate use. Establishing 
reimbursements for PRO screening or achieving qual-
ity of care benchmarks provides actionable patient 
follow-up while supporting quality improvement.
The final topic discussed by workshop participants 
was the necessity of minimizing workflow disruption. 
Participants agreed that workflow is often unique to 
each clinic, and general PRO standardization guide-
lines would not be effective. However, many agreed 
that ‘success stories’ of early PRO system adopters, and 
establishing meaningful PRO-based evaluation out-
comes demonstrating institutional value and/or cost 
savings, would encourage adoption.
Recommendations for PRO integration in the 
clinical setting focused on promoting the value of 
PRO assessment in routine care. For clinicians, rec-
ommendations centered on clinical situations where 
PROs provide immediately actionable information. 
For system-level stakeholders, recommendations look 
to establish PRO value with respect to quality-of-care 
evaluation.
Leveraging current clinical PRO systems to 
promote population-level use
Participant discussions examining the promotion of 
large-scale research and evaluation focused on over-
coming one key barrier: that the majority of current 
efforts to integrate PROs in the EHR have focused 
on demonstrating clinical relevance at the individ-
ual patient-level. Therefore the patient visit has been 
identified as the focal point for engagement, whereas 
population-level efforts may require collection and 
evaluation outside the clinical encounter. Opportuni-
ties identified focused particularly on demonstrating 
how PRO information in large-scale quality measure-
ment and improvement extend beyond the clinical 
visit. Research and quality improvement recommen-
dations focused on the necessity and complexity of 
large-scale PRO surveillance. Workgroups identified 
and prioritized a wide range of methodology, content, 
infrastructure and dissemination goals necessary to 
promote and sustain successful surveillance efforts.
Stakeholders also recommended that current col-
laborations and data networks be enlisted as contribu-
tors to standardize PRO integration across systems. 
PCORNet was specifically highlighted as a resource 
to promote best practices in population-level PRO use. 
PCORNet is a PCORI-funded effort which has cre-
ated a national, highly representative, patient-centered 
network to support more efficient clinical and observa-
tional research [21]. Even in development, PCORNet 
accelerated the adoption of routine PRO measurement 
within EHRs by convening a national PRO taskforce 
charged with identifying a common core PRO data 
collection.
Personalized medicine from the patient 
perspective
A meeting theme across all groups was that PROs are 
not ‘one size fits all’. PROs comprise a broad range of 
information, including hundreds of symptoms, func-
tional issues and topics that relate to quality of life. 
Effective measure deployment from this armamentar-
ium differs based on context, as different PRO informa-
tion will be clinically relevant and actionable at different 
times. More research is necessary to better understand 
how individual patient goals and preferences can tailor 
PRO selection for maximum, immediate and long-term 
patient benefit. For population-level PRO use, clini-
cians and health system representatives must also weigh 
in on matching measures to specific goals.
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Executive summary
•	 Curently, most electronic health record/patient-reported outcome integration efforts are implemented solely 
to inform individual patient care.
•	 Targeted research is needed to highlight the direct clinical applications and value of PROs to patients, 
providers, and healthcare systems.
•	 National Standards for patient-reported outcome collection and infrastructure are necessary.
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Immediate priorities & progress made
The EHR is a natural vehicle to collect and dis-
seminate PRO data across a broad variety of clini-
cal situations. However, current projects integrat-
ing PRO measures in EHRs are often designed for 
specific populations, clinical applications and qual-
ity improvement, which limits opportunities for 
expansion and scaling up across settings. Based on 
this workshop, immediate priorities were identified 
in three areas to promote PRO integration: educa-
tion, research and infrastructure (Box 2). First, for 
education, guidance for providers [22], institutions [23] 
and healthcare systems are limited [24,25], often (but 
not always [22]) focusing on PRO selection and score 
interpretation. Expanding efforts to address the com-
plexities of workflow and administration is neces-
sary. Second, for research, directed methodological 
research to address gaps in PRO conceptualization, 
measurement and implementation can provide the 
information needed to promote interpretability and 
relevance. Third, for infrastructure, additional tools 
and resources are needed to support broad infra-
structure development and demonstrate the value of 
PROs to major stakeholders. Together these elements 
best leverage EHR integration for widespread PRO 
adoption and regular use.
Priorities identified by workshop participants were 
incorporated into PCORI Funding Announcement 
development and, as a result, approximately 10% of 
the methods priority area portfolio reflects projects 
based on the priorities identified from this conven-
ing of diverse stakeholders. In addition, in follow-up 
to the 2013 PRO EHR meeting and in response to 
these immediate priorities, PCORI is now funding 
an effort to develop a ‘Users’ Guide for Integrating 
Patient-Reported Outcomes in Electronic Health 
Records’ (PCORI contract #MC-0013; PI: Snyder). 
This Users’ Guide will review the considerations for 
including PROs in EHRs, offering a range of alter-
natives rather than one ‘right’ answer, thereby allow-
ing clinics and institutions to determine what will 
work best in their environments. This effort will also 
identify key research questions for the field. A pub-
lic meeting presenting the Users’ Guide will offer an 
opportunity for participants to discuss voluntarily 
implementing PRO integration in consistent ways to 
enable data pooling.
Conclusion
Diverse stakeholders were convened to discuss exam-
ples of successful integration of PROs into the EHR 
to support clinical care, health system- or population-
level monitoring, quality management and research. 
Through group discussion and guided workshop ses-
sions, barriers to use of PRO data through the EHR 
were identified, allowing for creation of an agenda 
for future work. PCORI has begun to address this 
agenda through funding solicitations based on the 
priorities identified at the workshop, through PCOR-
Net and through a focused contract to create a guide 
for PRO integration in the EHR applicable across 
care settings.
Involving multiple stakeholder groups in the prob-
lem identification and articulation of priorities is a 
first step toward ensuring future work is responsive to 
the differing needs across the care delivery spectrum. 
Patient and clinician engagement addresses feasibil-
ity and relevance of PRO data collection. Health and 
IT professionals, as well as researchers, are necessary 
to address system interoperability while ensuring 
data accuracy. Healthcare plans, professional groups, 
accreditation organizations and the government can 
provide incentives to integrate, report and evalu-
ate PROs as part of routine care. PCORI and other 
influential groups, such as the NIH Collaboratory, are 
well-positioned to guide this effort [26]. Joint interdis-
ciplinary participation in this effort to standardize the 
patient voice within the EHR will ensure PROs are 
actionable, positioned to improve care quality and the 
patient healthcare experience at both the patient and 
system-level.
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